For an organisation the size and complexity of the NHS, system-wide change is a huge undertaking. So, when it became the world's first health system to commit to net zero in 2020, the implications were staggering. Alone, it is responsible for around 4–5% of the UK's carbon footprint and 30–40% of public-sector emissions.

Five years on, this was not an empty promise. According to the NHS's own five-year progress report, published in September 2025, its Carbon Footprint has fallen by 14% since the 2020 net zero strategy was launched.

Other organisations have made similar commitments, only to quietly ignore them later. What made the NHS different? How does it serve as an example to companies, NGOs, and other large institutions? And what lessons can professionals apply to their own careers?

The NHS Carbon Footprint Progress Is Real

All organisations try to frame their successes as positively as possible. However, the NHS has genuinely made tangible changes across the service.

Overall emissions are down. The NHS Carbon Footprint was estimated at 4.7 MtCO₂e in 2024/25, down from 5.5 MtCO₂e in 2019/20, a 14% reduction in the five years since the 2020 net zero strategy was launched.

High-impact clinical emissions have fallen sharply. Emissions from inhalers, nitrous oxide, and volatile anaesthetics have fallen by 33% since 2019/20. The clearest example is desflurane, an anaesthetic gas with a global warming potential more than 2,500 times that of CO2, an hour of its use warms the atmosphere by roughly as much as driving 200 to 400 kilometres in a petrol car, compared with just 5 to 10 kilometres for the lower-carbon alternative, sevoflurane. The NHS's work with the Royal College of Anaesthetists and the Association of Anaesthetists has helped deliver a 98% reduction in desflurane emissions.

Waste reduction has delivered real savings. Cutting nitrous oxide waste has avoided around £2.3 million per year in costs compared with 2019/20, showing how sustainability can overlap with better stock control, procurement, and operational efficiency.

The progress is real, but it has been concentrated in areas the NHS could tackle directly and quickly. What remains is more diffuse, harder to control, and touches nearly every part of how the service operates.

The Next Phase Is About the Parts Patients Never See

Every organisation tackling emissions tends to start with the changes that are contained, well understood, and within its direct control, the equivalent of the NHS's work on anaesthetic gases. Once those are addressed, what remains is rarely another single, defined fix. It becomes a question of the whole integrated system: how medicines are made, how supplies move, how thousands of separate organisations across a supply chain each play their part.

Much of that harder work sits within the NHS Carbon Footprint Plus. The NHS plans to continue reducing emissions from medicines while extending its attention across the supply chain. Its Net Zero Supplier Roadmap sets milestones covering suppliers throughout NHS procurement. If it works, emissions will fall without patients noticing any deterioration in their medication or care.

Procurement Is Where the NHS Can Move the Market

Companies can improve their own reported emissions by outsourcing a high-emissions activity to a third party. The emissions don't disappear, they simply shift from the company's own directly reported figures into a supplier's numbers, or into the far less scrutinised Scope 3 category. The organisation looks cleaner. Total emissions in the real world stay exactly the same.

The NHS's approach closes that loophole by design. Rather than measuring only what happens on its own estate, it holds its suppliers to the same standard, treating their emissions as part of its own responsibility rather than someone else's problem.

Verifying and reducing emissions across a supplier base this size is a monumental task. The NHS buys more than 600,000 products from over 80,000 national and global suppliers, spanning pharmaceuticals and medical equipment on one side and everything else the service relies on, from catering and cleaning to construction and IT, on the other. Supply-chain emissions from these sources were estimated at 12.4 MtCO₂e in 2024/25. Because many NHS suppliers also sell into other healthcare systems and sectors, requirements imposed here can push those companies to decarbonise across their entire business, not just the portion that serves the NHS. The NHS can therefore influence emissions far beyond its own estate.

This is where procurement starts to bite. From April 2027, all NHS suppliers, regardless of contract size, will need to publicly report their global emissions, targets, and carbon reduction plans across relevant global operations. From 2028, product-level carbon footprinting begins. For anyone selling into the NHS, sustainability will sit inside the bid, the product, the supply chain, and the commercial team.

What Is Holding Back NHS Net Zero, and Who Can Fix It?

The hard part is that the NHS must keep delivering care at full quality throughout. It cannot afford any drop in safety, reliability, or patient outcomes while that work is underway.

The work is no longer about announcing a target. It is about finding solutions to awkward problems without compromising ongoing services. This is exactly the kind of challenges that rewards innovative suppliers delivering outcomes based solutions as well as skilled, resourceful professionals, people who can walk into a complicated system, understand why a problem is genuinely hard rather than simply unsolved, and find a route through it.

For anyone thinking about their career, the lesson is this: the most meaningful work often sits exactly where a good idea meets the practical reality of delivering it inside a live, high-stakes system, making the idea actually work without anyone's care being compromised along the way.

The NHS has shown that a huge system can begin to move. Whether it can sustain that momentum through the harder, less visible work still to come is the real test. The next opportunity belongs to the people & companies who can spot the friction, win the trust of the clinicians, suppliers, and boards who need convincing a change is safe, and make that next change possible.